Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $783.0700 (2.1%) ($771.3470 - $788.7000) on Thu. Jun. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.53% (three month average) | RSI | 70 | Latest Price | $783.0700(2.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.2% a day on average for past five trading days. | Weekly Trend | REGN advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(44%) DIA(31%) VYM(28%) IWD(27%) | Factors Impacting REGN price | REGN will decline at least -0.765% in a week (0% probabilities). VXX(-24%) VIXM(-20%) TBT(-5%) ACES(-5%) UUP(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.765% (StdDev 1.53%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $760.04(3.03%) | 10 Day Moving Average | $751.62(4.18%) | 20 Day Moving Average | $746.18(4.94%) | To recent high | -5.7% | To recent low | 8% | Market Cap | $83.028b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |